About us
What we do
Where we work
Committee Structure
President
Our Members
Federation of Clinical Scientists
Staff Team
Get involved
Join us
Healthcare professionals
Industry
European Registration
Our Resources
News
Science Knowledge Hub
Education and Training
Careers in Laboratory Medicine
Policy and Media
Publications
Green Champions
Laboratory Medicine Learning Academy
Events and Awards
Event calendar
Grants and Bursaries
Awards and Prizes
National Meetings
Contact Us
LabMedUK24
Programme
Speakers
Venue information
Conference events
Ticket information
Login
You are here:
Association for Laboratory Medicine
Our Resources
Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes - Chris Parker (NICE Reference TA288)
NICE Guideline Summary
01 Jun 2013
by Chris Parker
Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes - Chris Parker (NICE Reference TA288)
ta288-dapagliflozin-in-combination-therapy-for-treating-type-2-diabetes.pdf
43 KB
Download
Return to listing
